Grown Rogue International (GRUSF) Share-based Compensation Growth (1y) (2012 - 2026)
Grown Rogue International (GRUSF) Share-based Compensation Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.47% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 47.06% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.60% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -133.31% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 8.33% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 40.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.27% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 48.29% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -24.33% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -89.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.21% |
| Dec 31, 2025 | -419.48% |
| Sep 30, 2025 | 419.47% |
| Jun 30, 2025 | -77.18% |
| Mar 31, 2025 | 2,455.68% |
| Apr 30, 2023 | 594.25% |
| Jan 31, 2023 | 641.73% |
| Apr 30, 2022 | -71.06% |
| Jan 31, 2022 | -91.57% |
| Oct 31, 2021 | 88.71% |
| Jul 31, 2021 | -72.76% |
| Apr 30, 2021 | -44.04% |
| Jan 31, 2021 | 384.15% |
| Oct 31, 2020 | 1,680.21% |
| Aug 31, 2018 | -96.09% |
| May 31, 2018 | 341.45% |
| Feb 28, 2018 | 262.85% |
| May 31, 2012 | -49.75% |